Impact of Vaccination Rates and Gross Domestic Product on COVID-19 Pandemic Mortality Across United States
Matveeva, O.; Ogurtsov, A. Y.; Shabalina, S. A.
Show abstract
AimThis study investigates factors influencing pandemic mortality rates across U.S. states during different waves of SARS-CoV-2 infection from February 2020 to April 2023, given that over one million people died from COVID-19 in the country. MethodsWe performed statistical analyses and used linear regression models to estimate age-adjusted and unadjusted excess mortality as functions of life expectancy, vaccination rates, and GDP per capita in U.S. states. Results and DiscussionStates with lower life expectancy and lower GDP per capita experienced significantly higher mortality rates during the pandemic, underscoring the critical role of underlying health conditions and healthcare infrastructure, as reflected in these factors. When categorizing states by vaccination rates, significant differences in GDP per capita and pre-pandemic life expectancy emerged between states with lower and higher vaccination rates, likely explaining mortality disparities before mass vaccination. During the Delta and Omicron BA.1 waves, when vaccines were widely available, the mortality gap widened, and states with lower vaccination rates experienced nearly double the mortality compared to states with higher vaccination rates (Odds Ratio 1.8, 95% CI 1.7-1.9, p < 0.01). This disparity disappeared during the later Omicron variants, likely because the levels of combined immunity from vaccination and widespread infection across state populations became comparable. We showed that vaccination rates were the only significant factor influencing age-adjusted mortality, highlighting the substantial impact of age-specific demographics on both life expectancy and GDP across states. ConclusionThe study underscores the critical role of high vaccination rates in reducing excess deaths across all states, regardless of economic status. Vaccination rates proved more decisive than GDP per capita in reducing excess deaths. Additionally, states with lower pre-pandemic life expectancy faced greater challenges, reflecting the combined effects of healthcare quality, demographic variations, and social determinants of health. These findings call for comprehensive public health strategies that address both immediate interventions, like vaccination, and long-term improvements in healthcare infrastructure and social conditions.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Projecting the impact of SARS-CoV-2 variants on the COVID-19 epidemic and social restoration in the United States: a mathematical modelling study 92%
- Stay-at-home and face mask policies intentions inconsistent with incidence and fatality during US COVID-19 pandemic 91%
- Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model 90%
Similar papers in this journal
- Comparison of COVID-19 vaccine prioritization strategies in the United States 92%
- Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia 92%
- An international comparison of age and sex dependency of COVID-19 Deaths in 2020 - a descriptive analysis 91%
Similar papers in this journal
Similar papers in this journal
- Is mandatory vaccination in population over 60 adequate to control the COVID-19 pandemic in E.U.? 92%
- Epidemiological differences in the impact of COVID-19 vaccination in the United States and China 91%
- Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19 91%
Similar papers in this journal
- Modeling the transmission of the SARS-CoV-2 delta variant in a partially vaccinated population 90%
- Estimates and determinants of SARS-CoV-2 seroprevalence and infection fatality ratio using latent class analysis: the population-based Tirschenreuth study in the hardest-hit German county in spring 2020 89%
- Seroprevalence, waning, and correlates of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Large-scale study of 35,193 blood donors conducted between June 2020 and September 2021 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.